Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001441383-12-000003
Filing Date
2012-08-20
Accepted
2012-08-20 12:28:02
Documents
1
Period of Report
2012-08-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4564
  Complete submission text file 0001441383-12-000003.txt   5918
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Issuer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 ELLIOTT AVE W., SUITE 400 SEATTLE WA 98119
Business Address
PHILIPS CRAIG (Reporting) CIK: 0001441383 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12465 | Film No.: 121044499